Courtney Breen
Stock Analyst at Bernstein
(4.48)
# 1,050
Out of 4,408 analysts
287
Total ratings
83%
Success rate
19.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Courtney Breen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintained: Hold | n/a | $350.53 | - | 29 | Jun 9, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | n/a | $56.24 | - | 30 | Jun 9, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,300 | $1,129.35 | +15.11% | 56 | Jun 9, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $160 | $124.30 | +28.72% | 29 | Jun 9, 2026 | |
| MRK Merck & Co. | Maintained: Hold | n/a | $114.90 | - | 38 | Jun 9, 2026 | |
| PFE Pfizer | Maintained: Hold | n/a | $26.00 | - | 37 | Jun 9, 2026 | |
| ABBV AbbVie | Maintained: Hold | n/a | $221.59 | - | 28 | Jun 9, 2026 | |
| MRNA Moderna | Maintained: Hold | n/a | $52.13 | - | 39 | Jun 9, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Sell | kr 175.00 | $283.55 | -38.28% | 1 | May 12, 2026 |
Amgen
Jun 9, 2026
Maintained: Hold
Price Target: n/a
Current: $350.53
Upside: -
Bristol-Myers Squibb Company
Jun 9, 2026
Maintained: Hold
Price Target: n/a
Current: $56.24
Upside: -
Eli Lilly and Company
Jun 9, 2026
Maintained: Buy
Price Target: $1,300
Current: $1,129.35
Upside: +15.11%
Gilead Sciences
Jun 9, 2026
Maintained: Buy
Price Target: $160
Current: $124.30
Upside: +28.72%
Merck & Co.
Jun 9, 2026
Maintained: Hold
Price Target: n/a
Current: $114.90
Upside: -
Pfizer
Jun 9, 2026
Maintained: Hold
Price Target: n/a
Current: $26.00
Upside: -
AbbVie
Jun 9, 2026
Maintained: Hold
Price Target: n/a
Current: $221.59
Upside: -
Moderna
Jun 9, 2026
Maintained: Hold
Price Target: n/a
Current: $52.13
Upside: -
Novo Nordisk A/S
May 12, 2026
Maintained: Sell
Price Target: kr 175.00
Current: $283.55
Upside: -38.28%